Renalytix Plc - ADR
NASDAQ:RNLX
| Market Cap (Intraday) | 29.16M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.32 |
| 50-Day MA | $0.39 |
| 200-Day MA | $0.63 |
Renalytix Plc - ADR Stock, NASDAQ:RNLX
1460 Broadway, 5-7 Cranwood Street, New York, New York 10036
United Kingdom
Phone: +1.646.397.3970
Number of Employees:
Description
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.